Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Exposure Risk Intensifying For Generic Drug Makers

Aug 08 2019

• By Jessica Merrill

Risk-ahead

Related Content

Opioid Makers May Have To Pay For Prevention Costs Of 'Man-Made Plague,' Judge Suggests

Jan 28 2019

J&J Gambles Oklahoma Opioid Trial Is Better Than Settlement; State Seeks $870m Per Year

May 29 2019

Purdue's 'Landmark' Settlement With Oklahoma May Be Harbinger Of MDL Resolution

Mar 27 2019

Opioid Litigation Clouds Loom Over Teva's Turnaround

Aug 07 2019

Mallinckrodt Creating Two Companies: Generics And Innovative Specialty Drugs

Dec 06 2018

Related Companies

Teva Pharmaceutical Industries Ltd.

Mallinckrodt plc

Endo, Inc.

Purdue Pharma L.P.

Johnson & Johnson

Additional Topics

Generic Drugs Legal Issues Sales & Earnings Business Strategies Commercial BioPharmaceutical

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.